Effect of Biofeedback Training to Reduce Anxiety

NCT05508919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-08-19

No results posted yet for this study

Summary

This study is planned to investigate the effectiveness of EMG, RESP, and TEMP Biofeedback Training to reduce symptoms of anxiety among the nursing students from one school, and to determine whether biofeedback training is associated to relax the minds and bodies of the anxious nursing students to cope with the distressing situation. Study subjects meeting the eligibility criteria will be randomized into two groups using randomly generated numbers: the Biofeedback training group and Control group. Biofeedback training will be used as an intervention vs the control. All the study subjects providing the consent to participate will be made to complete the study questionnaires (Demographic, Screening for Anxiety using the State-Trait Anxiety Inventory -STAI) at baseline and at post-intervention (after 4 weeks).

Conditions

Interventions

DEVICE

Biofeedback

EMG, RESP, and TEMP Biofeedback Training

OTHER

Writing Sessions

The subjects will be asked to take three 20-minute writing sessions and write about the given control topic about their daily events of the past week

Sponsors & Collaborators

  • Advanced Education & Research Center

    collaborator OTHER
  • University of Karachi

    lead OTHER

Principal Investigators

  • Shamoon Noushad, PhD · University of Karachi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-03-31
Completion
2023-05-31

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05508919 on ClinicalTrials.gov